Avadel’s shares crumble as narcolepsy drug delayed yet again, this time on patent issuenews2022-05-26T14:33:32+00:00May 26th, 2022|FierceBiotech|
Vertex scoops up Catalyst’s complement pipeline for $60M cashnews2022-05-26T13:47:56+00:00May 26th, 2022|FierceBiotech|
With the right partner, Pfizer gains fast-track tag for previously shelved NASH drugnews2022-05-26T12:12:33+00:00May 26th, 2022|FierceBiotech|
IN-ACTIV: NRx tanks as peptide fails NIH trial in severe COVID-19 patientsnews2022-05-26T11:38:55+00:00May 26th, 2022|FierceBiotech|
Biotech co-founder arrested on murder-for-hire chargesnews2022-05-26T10:29:51+00:00May 26th, 2022|FierceBiotech|
Flagship unveils ProFound Therapeutics with $75M to explore trove of new proteinsnews2022-05-25T21:03:00+00:00May 25th, 2022|FierceBiotech|
Forte fields demand to liquidate from top shareholder who says latest asset came ‘out of thin air’news2022-05-25T15:02:22+00:00May 25th, 2022|FierceBiotech|
BridgeBio’s CEO on staying alive, ‘motherhood and apple pie’news2022-05-25T14:36:12+00:00May 25th, 2022|FierceBiotech|
With failed COVID shot still dragging on earnings, CureVac tries to turn page to next-gen mRNA technews2022-05-25T13:45:23+00:00May 25th, 2022|FierceBiotech|
Antios rocked as hepatitis B safety signal sparks clinical hold, termination of collaborationnews2022-05-25T11:43:58+00:00May 25th, 2022|FierceBiotech|
